article_metadata: Francesca Conti Mattia Moratti Elena Sabattini Pier Luigi Zinzani
article_metadata: 10.3389/fimmu.2024.1517543
article_metadata: Front Immunol
article_metadata: 2025 Jan 13:15:1517543.
article_metadata: hodgkin (chl) hodgkin lymphoma (hl) pi3k inhibitor activated pi3k delta syndrome (apds) leniolisib
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39872539/
article_metadata: Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors Class I Phosphatidylinositol 3-Kinases / genetics Hodgkin Disease / drug therapy Primary Immunodeficiency Diseases / complications
article_metadata: Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors Class I Phosphatidylinositol 3-Kinases / genetics Hodgkin Disease / drug therapy Primary Immunodeficiency Diseases / complications Case Reports Female Humans Mutation Phosphoinositide-3 Kinase Inhibitors / therapeutic use Young Adult Class I Phosphatidylinositol 3-Kinases Phosphoinositide-3 Kinase Inhibitors PIK3CD protein, human Activated PI3K-delta Syndrome
article_metadata: PMC11770023
article_metadata: 39872539
article_metadata: Expert insights on Hodgkin's lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment
article_metadata: 2025